{"id":3334,"date":"2014-03-13T14:15:40","date_gmt":"2014-03-13T19:15:40","guid":{"rendered":"http:\/\/blogs.edf.org\/health\/?p=3334"},"modified":"2014-03-25T10:09:16","modified_gmt":"2014-03-25T15:09:16","slug":"no-more-california-dreamin-first-three-priority-products-proposed","status":"publish","type":"post","link":"https:\/\/blogs.edf.org\/health\/2014\/03\/13\/no-more-california-dreamin-first-three-priority-products-proposed\/","title":{"rendered":"No more just California Dreamin\u2019: First three priority products proposed"},"content":{"rendered":"

Jennifer McPartland, Ph.D.<\/em><\/a>,<\/em> is a Health Scientist.<\/em><\/p>\n

Today the California Department of Toxic Substances Control (DTSC) announced its first three draft priority products<\/a>\u2014the next major milestone in the implementation of its Safer Consumer Product (SCP) regulations to address chemicals of concern in the marketplace.\u00a0 While we\u2019re still at the start of a long process, today\u2019s announcement is the clearest indicator to date of the impact these regulations may have on consumer products.<\/p>\n

The release of the draft priority products follows DTSC\u2019s release last September<\/a> of its candidate chemicals list and from within this list, the subset initial candidate chemicals list.\u00a0 Together with the initial candidate chemical list, the identification of the draft priority products now defines the possible set of chemical-product combinations that may head toward alternatives assessment.\u00a0 Read on for a description of the chemicals and products and of the next phase of regulatory actions.\u00a0 <\/p>\n

The candidate chemicals list and \u201cinitial\u201d candidate chemicals list<\/b><\/p>\n

The candidate chemicals list includes about 1100 chemicals and chemical groups (about 2300 individual chemicals in total) that exhibit a hazard trait or an environmental or toxicological endpoint and<\/i> are either 1) found on one or more specified authoritative lists<\/a> or 2) listed by DTSC using specified criteria detailed in the SCP regulations.\u00a0 The initial candidate chemicals list is a subset of this list and includes chemicals that are also found on lists indicative of exposure.\u00a0 There are 153 initial candidate chemicals and chemical groups (248 individual chemicals in total).\u00a0 DTSC has developed a helpful diagram<\/a> to explain the relationship between the candidate and initial candidate lists.\u00a0 The specific names of the chemicals on these lists can be accessed here<\/a>.<\/p>\n

The draft priority products announced today<\/b><\/p>\n

DTSC used the initial candidate chemicals to identify the draft priority products<\/a>.\u00a0 The agency searched for products containing the initial candidate chemicals and narrowed those down to 3 priority products based on \u201cthe potential adverse impacts of [the product\u2019s] candidate chemical(s) and adverse impacts due to potential exposures during the life cycle of the product.\u201d\u00a0 Further information about this process can be found here<\/a>.<\/p>\n

Below are the draft priority products and the initial candidate chemicals present in them.\u00a0 Together, they delineate the proposed chemical-product combinations that will move forward to the next phase of the SCP regulations.\u00a0 Helpful supplemental information can be found here<\/a>.<\/p>\n\n\n\n\n\n\n
Draft Priority Product<\/td>\nChemical or Chemical Group<\/td>\nKey Health Impacts of Concern<\/td>\nAdditional Info on DTSC\u2019s Website<\/td>\n<\/tr>\n
Children\u2019s foam-padded sleeping products<\/td>\n1,3-dichloro-2-propyl phosphate (TDCPP), also known as chlorinated \u00a0 Tris<\/td>\nHuman carcinogen and Endocrine disruption<\/td>\nhttp:\/\/bit.ly\/1gnHo5M<\/a><\/td>\n<\/tr>\n
Wet or “uncured” spray polyurethane foam (SPF)<\/td>\nDiisocyanates<\/a>*<\/td>\nRespiratory effects (e.g., asthma), Skin Irritation, Suspected human \u00a0 carcinogen<\/td>\nhttp:\/\/bit.ly\/1i8ffzE<\/a><\/td>\n<\/tr>\n
Paint and varnish removers, paint and varnish strippers, and surface \u00a0 cleaners<\/td>\nMethylene Chloride**<\/td>\nHuman carcinogen, Skin and eye irritation, Unconsciousness, Death<\/td>\nhttp:\/\/bit.ly\/1iFDIeA<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*The diisocyanates, MDI<\/a> and TDI<\/a>, are EPA action plan chemicals<\/a>.<\/p>\n

**Methylene chloride<\/a> is an EPA work plan chemical<\/a>.<\/p>\n

 <\/p>\n

The next phase of the SCP regulations<\/b><\/p>\n

DTSC will be taking public comment on these proposed chemical-product combinations before finalizing them.\u00a0 This could take up to 1.5 years.\u00a0 Once finalized, businesses responsible for these products\u2014beginning with their manufacturers but if necessary moving down the supply chain to retailers and product distributors\u2014will be subject to product notification requirements<\/a>, and may be subject to the chemical alternative analysis requirements<\/a>, of the regulations. DTSC\u2019s frequently asked questions<\/a> (bottom of page) and flowchart<\/a> [PDF] provide helpful background information regarding these requirements.<\/p>\n

Still to come is the DTSC chemical alternatives analysis guidance<\/a> that will detail how the agency expects the alternatives analysis requirement of the SCP regulations to be implemented.<\/p>\n

In recent months, several groups have released principles for chemical alternatives assessment.\u00a0 These include the Commons Principles for Alternatives Assessment<\/a> jointly led by EDF, BizNGO, Lowell Center for Sustainable Production and Massachusetts Toxics Use Reduction Institute with signatories from companies, universities, governments, and environmental health groups; and a set of principles<\/a> developed by manufacturing trade associations.\u00a0 While there are some similarities between these sets of principles, they also differ in key ways.\u00a0 For example, the Commons Principles include an explicit call for transparency with regard to alternatives assessment methodologies employed, data used to characterize alternatives, assumptions made and decision making rules applied.\u00a0 Transparency elements are notably absent from the trades\u2019 principles.<\/p>\n

For the public and businesses to understand and make use of the results of an alternatives assessment, the process must be transparent.<\/p>\n

In a related development, the Interstate Chemicals Clearinghouse (IC2)<\/a>, an association of state, local, and tribal governments, recently finalized its detailed IC2 chemical alternatives assessment guide<\/a>, 20 months in the making.\u00a0 The IC2 document provides a protocol for how to conduct an alternatives assessment.\u00a0 This protocol is guided by a defined set of 6 principles, one of which addresses transparency: \u201cAll assumptions, data sources, data quality, decisions, etc., should be documented and explained. For example, decision methods require establishing weighting criteria. The values selected for the relative weightings should be communicated and justified.\u201d<\/p>\n

It will be every interesting to see how DTSC\u2019s alternatives guidance will compare with these other related efforts.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Jennifer McPartland, Ph.D., is a Health Scientist. Today the California Department of Toxic Substances Control (DTSC) announced its first three draft priority products\u2014the next major milestone in the implementation of its Safer Consumer Product (SCP) regulations to address chemicals of concern in the marketplace.\u00a0 While we\u2019re still at the start of a long process, today\u2019s …<\/p>\n","protected":false},"author":5105,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[44],"tags":[39995,200,5013,5019,39986,5010,134],"coauthors":[],"class_list":["post-3334","post","type-post","status-publish","format-standard","hentry","category-policy","tag-alternatives-assessment","tag-california","tag-children-safety","tag-consumer-products","tag-endocrine-disruption","tag-flame-retardant","tag-states"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts\/3334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/users\/5105"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/comments?post=3334"}],"version-history":[{"count":0,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts\/3334\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/media?parent=3334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/categories?post=3334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/tags?post=3334"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/coauthors?post=3334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}